ArticleJournal of applied research in intellectual disabilities : JARID2025
The Use of the Anxiety, Depression and Mood Scale (ADAMS) as a Screening Instrument for Depression and Mental Health Diagnoses in a Down Syndrome Specialty Clinic.
Article in Journal of applied research in intellectual disabilities : JARID, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionThe Anxiety, Depression and Mood Scale (ADAMS), a mental health screening tool developed for individuals with intellectual disabilities, has yet to be evaluated in adults with Down syndrome. We included the ADAMS in a Dementia Protocol.
methodWe reviewed the charts of 71 adults with Down syndrome seen in a specialty clinic and collected ADAMS data from our quality improvement project. We evaluated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the ADAMS at five cutoff points to identify optimal screening thresholds for adults with Down syndrome.
resultsCutoff points set at two points below the 75th percentile scores of the original ADAMS publication presented optimal sensitivity of 81.82%, specificity of 82.93%, PPV of 72.00% and NPV of 89.47%.
conclusionFor adults with Down syndrome, we suggest alternate thresholds, generally two points below the original ADAMS thresholds, to adequately capture mental health concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.